It is estimated that more than 21 million deaths have been averted, globally, by measles vaccination since 2000. Despite this undeniable success, measles elimination is facing various challenges including the inability of health systems to reach more children. Measles vaccine coverage has plateaued over the past 10 years to levels incompatible with measles elimination goals, vaccine hesitancy sometimes fueled by increasingly vocal anti-vaccine groups is posing new challenges, rumors spread even faster than the disease through social media, outbreaks of various scales are reported in various countries in Africa as well as in countries of Europe and North America that had virtually eliminated measles. The special issue aims to documents innovations that have impacted or have the potential to help accelerate progress towards measles elimination targets by focusing on immunization service delivery, community demand for vaccination and advocacy, injection safety, supply chain management and cold chain, immunization financing, measles laboratory, measles and rubella campaigns planning an implementation, and more.
Guest editors: Robert Davis, James Goodson, Raoul Kamadjeu
Contact: The Pan African Medical Journal, Park Suites Building, Nairobi, Kenya email@example.com
Download the complete supplement [PDF - 7 Mb]
|Articles published in PAMJ are Open Access and distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0).|
The Pan African Medical Journal (ISSN: 1937-8688) is a subsidiary of the Pan African Medical Journal. The contents of this journal is intended exclusively for professionals in the medical, paramedical and public health and other health sectors.
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, ESCI
Physical address: Kenya: 3rd Floor, Park Suite Building, Parkland Road, Nairobi. PoBox 38583-00100, tel: +254 (0)20-520-4356 | Cameroon: Immeuble TechnoPark Essos, Yaounde, PoBox: 10020 Yaounde, tel: +237 (0)24-309-5880